Atlas Trials

First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer

Clinical trial NCT05189457 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05189457
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerStage IV Prostate Cancer
Start date
2022-01-25
Primary completion
2027-07-15
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.